AACR 2024: Apr 7-10
We are excited to be attending the American Association of Cancer Research (AACR) 2024 annual conference from April 5-10 in San Diego, California! Set up…
Read moreBiocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
Beijing, China, March 25, 2024 --Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company that drives the research and development of novel…
Read moreBIO-Europe Spring 2024 | Schedule 1-on-1 Meetings with Biocytogen
Biocytogen’s antibody BD and licensing team is pleased to attend and host 1-on-1 meetings at BIO-Europe Spring, taking place March 18-20, 2024 in Barcelona, Spain.…
Read moreMar 2024 Newsletter
New Animal Models Humanized Immune-Checkpoint Mice Product Catalog Number B-hMADCAM1 mice 111627 B-hDR4 mice 111986 B-hMICA mice 112161 B-hCD3E/hCD19/hCD20 mice 113171 B-hTGFBR2/hFAP mice 113138 B-hPD-1/hPD-L1/hSIRPA/hCD47,Tg(hLILRB2/hLILRB3)…
Read moreJoin us at World ADC London 2024: Mar 13-14
Join us at the World ADC London 2024 conference in London, UK from March 13-14! Our Chief Scientific Officer and Senior Director of New Drug…
Read moreJoin us at SAPA-GP Annual Conference 2024: Mar 8-9
Join us at the SAPA-GP Annual Conference 2024 in Pennsylvania from March 8-9, 2024! Whether you need humanized models, pharmacology services, or are seeking…
Read moreWebinar: Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies
Our webinar “Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies" will be live at 12PM EDT on March 27, 2024. About the webinar:…
Read moreBiocytogen Symposium 2024: New Targets, New Therapeutics
[embed]https://youtu.be/TPV_3gMmUvE?si=qgqV-_b_0euuhL5I[/embed] Thanks to all who joined us at the 2024 Biocytogen Symposium! Your participation made this event a tremendous success. Whether you joined us in person or…
Read moreBiocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
Beijing, China, February 19, 2024 – Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces an antibody evaluation and option agreement with Gilead Sciences,…
Read moreWebinar: Preclinical Pharmacology Services to Support Evaluation of Novel Cell & Gene Therapies
Our webinar “Preclinical Pharmacology Services to Support Evaluation of Novel Cell & Gene Therapies" was live at 12PM EST on February 28, 2024. About the…
Read more